The fourth subset, including clusters 20 and 23, is immune-regulatory TAMs characterized by the upregulation of immune-suppressive genes, such as CD274, CCL2, IL10, and TGFB2, and are prevalent in primary CRC in treatment-naïve tumors (Fig. 3c, right panel). Here, CCL2 is linked to colorectal carcinoma.